Announcements Trials
Browse Landscape

Phase

Phase 2 4Phase NA 3Phase 1 3Phase EARLY_PHASE1 2Phase 3 2Phase 2/3 1

Status

Withdrawn 1Terminated 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Gynecologic 1Gastrointestinal 1

Conditions

Uterine Cervical Dysplasia 1Colonic Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 26pembrolizumab 17Radiotherapy 17Specimen Handling 16Nivolumab 15Cyclophosphamide 14Temozolomide 11Biopsy 11fludarabine 9Fluorodeoxyglucose F18 9X-Rays 8Etoposide 7Bevacizumab 7Standard of Care 6Radiation 6Paclitaxel 6Dexamethasone 6Cisplatin 6Carboplatin 6Surgical Procedures, Operative 5Ipilimumab 5Doxorubicin 5Aspirin 5venetoclax 4fluciclovine F-18 4atezolizumab 4abemaciclib 4Vincristine 4Rituximab 4Radiosurgery 4

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Curcumin × 1 year × Clear all
NCT02724202 2026-02-06

Curcumin in Combination With 5FU for Colon Cancer

Baylor Research Institute

Phase EARLY_PHASE1 Terminated
15 enrolled
Gastrointestinal

Colonic Neoplasms

NCT02554344 2026-01-30

Effect of Curcumin in Treatment of Squamous Cervical Intraepithelial Neoplasias (CINs)

Baylor Research Institute

Phase EARLY_PHASE1 Withdrawn
Gynecologic

Uterine Cervical Dysplasia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡